Status:
WITHDRAWN
Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches
Lead Sponsor:
McMaster University
Conditions:
Postdural Puncture Headache
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Postdural puncture headache (PDPH) is a severe, debilitating complication of dural puncture that can arise from insertion of an epidural or spinal needle for labour analgesia. Presently, the conservat...
Eligibility Criteria
Inclusion
- Age 18-45
- Confirmed PDPH as per ICHD-3 diagnostic criteria
Exclusion
- American Society of Anesthesiologists (ASA) class 4 and above
- History of chronic headaches or migraines requiring prescription medication
- Known nasal septal deformity or abnormality
- Known allergy to amide anesthetics
- Intrathecal catheters
- Patients who received EBP on the initial presentation with PDPH who declined a trial of conservative management
- Postpartum complication delaying maternal discharge
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04515901
Start Date
December 1 2021
End Date
November 11 2022
Last Update
December 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University Medical Centre
Hamilton, Ontario, Canada, L8S 4K1